The 2013 Janssen Industry Excellence Awards close this Friday 27 September. This is the last chance in 2013 to nominate an individual or organisation that has made a significant contribution to the biotechnology industry. [ + ]

Advancements in fighting cancer are also driving up the cost of cancer drugs, which could present a major strain on PBS resources, according to Flinders University’s Michael Sorich. [ + ]

International climate scientists, led by the Lawrence Livermore National Laboratory (LLNL) in the United States, have reported strong evidence of the human influence on climate change. [ + ]

Phosphagenics (ASX:POH) has started dosing volunteers in a phase I trial of pain patch candidate TPM/oxymorphone and aims to enter phase II in 1H14. [ + ]

Two Pharmaxis (ASX:PXS) independent directors have retired and the newly-restructured company is using the opportunity to shave down its board size. [ + ]

Researchers at the University of Adelaide have shown that while the immune cells known as macrophages have a role to play in the normal function of the breast, at certain stages in the menstrual cycle they may also help to make the breast more susceptible to cancer. [ + ]

Researchers from James Cook University (JCU) and The Townsville Hospital have developed a highly sensitive and rapid multiplex diagnostic test for melioidosis. Their findings have been published in the journal Diagnostic Microbiology and Infectious Diseases. [ + ]

Freehills Patent Attorneys has appointed another a partner in their pharmaceutical and biotechnology practice. [ + ]

A poster presentation detailing the activity of BioDiem's (ASX:BDM-I) animicrobial BDM-I in nearly 70 fungal infections has been presented at an interscience conference. [ + ]

The combination of lower shark numbers and coral loss is having an impact on fish communities of coral reefs. [ + ]

Applications are open for The Centenary Institute Lawrence Creative Prize for early-career biomedical researchers. [ + ]

Calzada (ASX:CZD) has submitted an application with the US FDA for its NovoSorb wound dressings in procedures involving topical negative pressure (TNP). [ + ]

Genetic Technologies (ASX:GTG) has announced the latest settlement in its US patent enforcement efforts and finalised the terms for a proposed US$5m issue of convertible notes. [ + ]

A genetic study - carried out by scientists at the Universities of Oxford, St Andrews and Bristol and the Max Plank Institute for Psycholinguistics - has identified a biological process that influences whether we are right- or left-handed. [ + ]

The 2013 UNSW Innovation Awards winners have been announced. The awards recognise and reward the effort and ingenuity of UNSW staff and students in the creation and transfer of new knowledge and innovations into society and the economy. [ + ]